MetLife Investment Management’s Caesarstone CSTE Stock Holding History

MetLife Investment Management’s Portfolio CSTE Stock Details CSTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-5,923	Closed	-$33.8K	–	2797
2022 Q4	$33.8K	Sell	5,923 -6,612	-53%	-$49.4K	﹤0.01%	2790
2022 Q3	$117K	Buy	12,535 +3,568	+40%	+$34.3K	﹤0.01%	2600
2022 Q2	$81.9K	Sell	8,967 -3,621	-29%	-$34.6K	﹤0.01%	2758
2022 Q1	$132K	Buy	12,588 +4,480	+55%	+$53.1K	﹤0.01%	2561
2021 Q4	$91.9K	Hold	8,108	–	–	﹤0.01%	2431
2021 Q3	$101K	Buy	+8,108	New	+$109K	﹤0.01%	2435
2020 Q4	–	Sell	-11,687	Closed	-$115K	–	2282
2020 Q3	$115K	Hold	11,687	–	–	﹤0.01%	2155
2020 Q2	$138K	Hold	11,687	–	–	﹤0.01%	2093
2020 Q1	$124K	Hold	11,687	–	–	﹤0.01%	1964
2019 Q4	$176K	Hold	11,687	–	–	﹤0.01%	2047
2019 Q3	$194K	Hold	11,687	–	–	﹤0.01%	1966
2019 Q2	$176K	Hold	11,687	–	–	﹤0.01%	2107
2019 Q1	$182K	Hold	11,687	–	–	﹤0.01%	2024
2018 Q4	$159K	Hold	11,687	–	–	﹤0.01%	2037
2018 Q3	$217K	Buy	+11,687	New	+$205K	﹤0.01%	2033

Other funds holding CSTE

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MTWSIF

Mivtachim The Workers Social Insurance Fund Tel Aviv, Israel $789M AUM 73.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

MetLife Investment Management's CSTE Position: Q1 2023 in Review

MetLife Investment Management sold out of Caesarstone (CSTE) in Q1 2023, closing a stake of 5,923 shares — an estimated $33.8K sold.

MetLife Investment Management first reported a position in CSTE in Q3 2018 and held it in 15 quarters. The position peaked at $217K in Q3 2018. 80 funds tracked by Wall St. Rank hold CSTE as of Q1 2023.

MetLife Investment Management reported no remaining Caesarstone position as of Q1 2023 after selling out during the quarter.
MetLife Investment Management sold 5,923 Caesarstone shares in Q1 2023, an estimated $33.8K.
MetLife Investment Management first reported a position in Caesarstone in Q3 2018 and held it in 15 quarters.
MetLife Investment Management's Caesarstone position peaked at $217K in Q3 2018.
80 funds tracked by Wall St. Rank held Caesarstone as of Q1 2023.

Based on MetLife Investment Management's 13F filing for Q1 2023, filed 15 May 2023.